Using a Recently Approved Tumor Mutational Burden Biomarker to Stratify Patients for Immunotherapy May Introduce a Sex Bias.

ABSTRACT:

SUBMITTER: Sinha N 

PROVIDER: S-EPMC9848582 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature